Literature DB >> 30553566

The Bumpy Road to CAR Activation.

Valérie Janelle1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30553566      PMCID： PMC6320339          DOI： 10.1016/j.ymthe.2018.12.003

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

1.  Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.

Authors:  John Maher; Renier J Brentjens; Gertrude Gunset; Isabelle Rivière; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

2.  Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.

Authors:  Alexander I Salter; Richard G Ivey; Jacob J Kennedy; Valentin Voillet; Anusha Rajan; Eva J Alderman; Uliana J Voytovich; Chenwei Lin; Daniel Sommermeyer; Lingfeng Liu; Jeffrey R Whiteaker; Raphael Gottardo; Amanda G Paulovich; Stanley R Riddell
Journal:  Sci Signal       Date:  2018-08-21       Impact factor: 8.192

3.  T cell signaling. Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion.

Authors:  Julia M Marchingo; Andrey Kan; Robyn M Sutherland; Ken R Duffy; Cameron J Wellard; Gabrielle T Belz; Andrew M Lew; Mark R Dowling; Susanne Heinzel; Philip D Hodgkin
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

Review 4.  CAR T-cell Therapy: A New Era in Cancer Immunotherapy.

Authors:  Androulla N Miliotou; Lefkothea C Papadopoulou
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

5.  Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy.

Authors:  Paul F Robbins; Mark E Dudley; John Wunderlich; Mona El-Gamil; Yong F Li; Juhua Zhou; Jianping Huang; Daniel J Powell; Steven A Rosenberg
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

Review 6.  Therapeutic T cell engineering.

Authors:  Michel Sadelain; Isabelle Rivière; Stanley Riddell
Journal:  Nature       Date:  2017-05-24       Impact factor: 49.962

7.  Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.

Authors:  C Imai; K Mihara; M Andreansky; I C Nicholson; C-H Pui; T L Geiger; D Campana
Journal:  Leukemia       Date:  2004-04       Impact factor: 11.528

8.  In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.

Authors:  William Y Ho; Hieu N Nguyen; Matthias Wolfl; Juergen Kuball; Philip D Greenberg
Journal:  J Immunol Methods       Date:  2006-01-26       Impact factor: 2.303

9.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

10.  Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes.

Authors:  T Brocker; K Karjalainen
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.